» Articles » PMID: 32690491

Dexamethasone for COVID-19: Preliminary Findings

Overview
Journal Drug Ther Bull
Specialty Pharmacology
Date 2020 Jul 22
PMID 32690491
Citations 13
Affiliations
Soon will be listed here.
Abstract

Effect of dexamethasone in hospitalised patients with COVID-19 - preliminary report. https://doi.org/10.1101/2020.06.22.20137273.

Citing Articles

Opportunity for severe and critical COVID-19 pneumonia treatment with corticosteroids: a retrospective cohort study.

Chen F, Zong L, Li Y, Zhu H, Xu S, Xu J J Thorac Dis. 2024; 16(9):5688-5697.

PMID: 39444892 PMC: 11494557. DOI: 10.21037/jtd-24-329.


Management Strategies of COPD during the COVID-19 Pandemic.

Pandey A, Verma A, Singh A, Kant S, Dixit R, Chaudhary S Tanaffos. 2023; 22(1):4-6.

PMID: 37920312 PMC: 10618588.


Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target.

Yang Z, Nicholson S, Cancio T, Cancio L, Li Y Front Immunol. 2023; 14:1100461.

PMID: 37006238 PMC: 10064147. DOI: 10.3389/fimmu.2023.1100461.


Management of chronic respiratory diseases during viral pandemics: A concise review of guidance and recommendations.

Sharma P, Mishra M, Dua R, Saini L, Sindhwani G J Family Med Prim Care. 2023; 11(11):6633-6639.

PMID: 36993046 PMC: 10041299. DOI: 10.4103/jfmpc.jfmpc_974_21.


The Impact of COVID-19 on Cancer.

Li Y, Wang X, Wang W Infect Drug Resist. 2021; 14:3809-3816.

PMID: 34557004 PMC: 8455900. DOI: 10.2147/IDR.S324569.